Abstract: Sleep disordered breathing has been linked to adverse cardiovascular outcomes in the general population. In pregnancy, sleep disordered breathing has also been linked to pathologic disorders that have been associated with long term cardiovascular and metabolic outcomes such as gestational hypertensive disorders and gestational diabetes mellitus. Endothelial dysfunction, sympathetic stimulation and inflammation are among the mechanisms proposed to explain the association with adverse outcomes. In addition to mechanistic research, future efforts need to focus on the effect of therapy on such outcomes.
INTRODUCTION
The course and outcomes of pregnancy are affected by many physiological changes and events. Pathological issues can also present or become clinically manifested during pregnancy. These changes can affect the health of both mother and fetus. The physiologic mechanisms of disease that are focused upon are primarily those that occur during waking hours.
Humans spend approximately one third of life asleep [1] . It is possible that pathologic changes occurring during sleep or resulting in poor sleep may also affect pregnancy outcomes. Like so many aspects of a woman's life, sleep is profoundly altered in many pregnant women by pregnancy physiology [2] . Sleep disruption starts in the first trimester and is related to factors such as nocturnal micturition and nocturnal heartburn. As pregnancy progresses, musculoskeletal discomfort related to ligamental relaxation, weight gain or leg cramps may disrupt sleep. Obstetric factors such as uterine contraction or fetal movement may also contribute to sleep fragmentation. Anatomical and physiological changes also occur in pregnancy leading to disturbed sleep, poor sleep quality and more frequent snoring as well as decreased daytime alertness [3] . Prevalence of self reported snoring is significantly higher in pregnancy affecting 14-45% of pregnant women in most studies [4] [5] [6] compared to 4% of the non-pregnant population. Excessive daytime sleepiness is also quite prevalent in the pregnant *Address correspondence to this author at the Warren Alpert Medical School of Brown University, The Miriam Hospital, Department of Medicine, 146 West River St, Providence, RI 02904, USA; Tel: (401) 793-7358; Fax: (401) 793-7801; E-mail: ghada_bourjeily@brown.edu population [7] and appears to worsen with the course of pregnancy [8] .
While many aspects of abnormal sleep may contribute to adverse outcomes, this manuscript will focus on pregnancy outcomes associated with sleep disordered breathing (SDB) while another review by Dr Tauman in this issue discusses fetal outcomes.
PREGNANCY PHYSIOLOGY
Cardiopulmonary physiology and sleep related physiologic changes have been reviewed in recently published manuscripts [9, 10] . Briefly, pregnancy is associated with changes in upper airway size [11, 12] as well as mucosal edema and friability [13] [14] [15] [16] which result in a decrease in airway patency and higher Mallampati grades [17] . Oxygen consumption increases by about 20% and functional residual capacity (FRC) decreases by about 20% near term with a more pronounced reduction in the supine position [18] . Cardiac output rises significantly in pregnancy but drops in the supine position in the latter half of pregnancy [19, 20] . The reduced FRC and cardiac output may potentially affect supine oxygenation. Progesterone, a strong respiratory stimulant increases minute ventilation during the wake period [21] and estrogen decreases REM sleep [22] [23] [24] . These hormonal effects may theoretically have some protective effects against SDB.
SDB AND ADVERSE CARDIOVASCULAR OUT-COMES
SDB and its potential consequences such as sleep fragmentation, short sleep duration and desaturations have been associated with a variety of well characterized physiological responses such as sympathetic activation, endothelial dysfunction, systemic inflammation, and metabolic dysregulation [25] as well as a wide range of adverse outcomes. Of those many outcomes, cardiovascular disease is particularly relevant to pregnancy complications such as preeclampsia, gestational diabetes and intrauterine growth restriction. On the one hand these adverse outcomes share similar risk factors with cardiovascular disease; on the other, some of these outcomes have been associated with a higher risk of developing premature cardiovascular disease [26] [27] [28] .
Links between SDB and adverse cardiovascular outcomes including hypertension [29, 30] , congestive heart failure both systolic and diastolic [31] , acute stroke, [32] arrhythmia and cardiac ischemia [33] [34] [35] [36] have been evaluated. Although the physiologic link has been studied, establishing OSA as a direct causal event for these cardiovascular events has been more challenging [31, 37] . Moreover, many of the studies available lack the power to evaluate the effect of gender differences on such outcomes. The Sleep Heart Health study has shown a less robust effect of OSA on adverse cardiovascular outcomes in women [31] ; such results are possibly related to a more delayed timing of these outcomes in women compared to men.
Several studies have also shown a relationship between diabetes and OSA. OSA was diagnosed in 86% of obese or overweight diabetic subjects in the Sleep AHEAD study [38, 39] . Despite a potential selection bias in this study, these findings remain quite remarkable. OSA has also been associated in many studies with measures of abnormal glucose metabolism and elevated glycosylated hemoglobin [40] [41] [42] [43] . Snoring has also been associated with abnormal glucose tolerance [44] as well as a two-fold increased risk of developing type II diabetes mellitus over a period of ten years (RR 2.03, 1.17-2.40 95% CI) [45] . Snoring was also shown to be an independent risk factor for type II diabetes in women in a large cross-sectional study [46] .
ADVERSE PREGNANCY OUTCOMES
The majority of studies evaluating the association between SDB and adverse pregnancy outcomes have a cross sectional design [4] [5] [6] [47] [48] [49] [50] and do not follow women longitudinally through pregnancy, precluding clear conclusions. Furthermore, the variables evaluated in these studies have differed, with some evaluating outcomes of snoring, others using questionnaires that have been validated in the non-pregnant population but not in pregnancy, while a small number of studies have evaluated outcomes of polysomnographically (PSG) diagnosed OSA. Physiologically, pregnancy can be thought of as a dynamic status that may affect the characterization of outcomes and exposures. Snoring in the first trimester likely suggests a condition predating pregnancy, whereas snoring that develops in the third trimester may be related to a pregnancy condition. The same is true for other conditions such as hypertension diagnosed in pregnancy. In addition, many of the outcomes that manifest clinically or are diagnosed in the third trimester such as preeclampsia, have their roots developing much earlier in pregnancy. For that reason, in order to evaluate causality of SDB, an exposure early in pregnancy would be ideal.
GESTATIONAL HYPERTENSIVE DISORDERS
Gestational hypertensive disorders include both transient gestational hypertension and preeclampsia. Gestational hypertension is defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg in a previously normotensive pregnant woman who is at ≥20 weeks of gestation and has no proteinuria [51, 52] . If and when proteinuria develops (>300 mg proteins in a 24 hour urine collection or more than 2+ on a urine dipstick), gestational hypertension is then termed preeclampsia. Gestational hypertension complicates about 6% of all pregnancies [53] . Chronic hypertension may also complicate a small percentage of pregnancies (3%) [54] but elevated blood pressures are usually found before 20 weeks of gestation and persist beyond 12 weeks postpartum. Preeclampsia is a significant cause of maternal and fetal morbidity and mortality. It is associated with adverse maternal outcomes such as pulmonary edema, liver function abnormalities, renal failure and neurological complications, as well as adverse fetal outcomes including growth restriction, oligohydramnios and preterm birth.
In the past decade, numerous studies have evaluated the association between SDB and gestational hypertensive disorders [4-6, 47-50, 55-59] . The bulk of these studies evaluated snoring rather than polysomnographically diagnosed OSA [4] [5] [6] [47] [48] [49] [50] and found a positive association with an adjusted odds ratio ranging from 1.82 (95% CI 1.16-2.84) [49] to 2.9 (95% CI 1.03-8.3) [5] . Most studies have adjusted for weight, weight gain and age [48, 49] while a few had a more extensive model that included diabetes, chronic hypertension, renal disease, multiple gestations and prior preeclampsia [4] . These findings suggest that snoring is possibly an independent predictor of gestational hypertensive disorders.
On the other hand, a study by Yin et al. evaluated a convenience selection of pregnant women oversampled for women with adverse pregnancy complications and recruited either during hospitalization or a routine prenatal visit [50] . This study used nocturnal oximetry as a surrogate for OSA and found no correlation between nocturnal desaturations and adverse pregnancy outcomes. Although the goal to achieve 80% power in this study was 100 normal pregnant women and 100 women with hypertension or growth restriction, the investigators were only able to recruit 78 normal pregnant women. Another study recruited pregnant women and non pregnant controls and screened them for snoring [47] . The study found a low incidence of habitual snoring (2.5%) and a low incidence of preeclampsia (about 2%) and no significant association between the two conditions. The lack of an association in the latter two studies is likely related to sample size and selection, with only a small percentage of subjects having the defined outcome and variable, and possibly because OSA was defined by the presence of oxygen desaturations and did not assess for flow limitations.
Some studies have considered positive screens for OSA as women who either screened high risk on the Berlin questionnaire [60] -or those with an Epworth Sleepiness Scale score (ESS) >10 [58] . ESS has not been shown to be a sensitive or specific measure of SDB in large cross sectional studies in the non-pregnant population [61] . This test is likely less specific in the pregnant population given the hormonal and inflammatory milieu of pregnancy and the physiologic sleep fragmentation. Berlin questionnaire has also been found to have a low sensitivity (35%) and specificity (63.8%) when 100 hospitalized pregnant women were screened for OSA between 26-39 weeks of gestation. Outcomes and associations in such studies are therefore harder to compare to others that have used mainly snoring or an actual diagnosis of OSA.
Fewer studies have evaluated PSG-diagnosed OSA and gestational hypertensive disorders. Louis et al. performed a retrospective case-control study comparing women diagnosed with OSA to a group of obese controls and a group of lean controls that do not carry the diagnosis [57] . The study has found a significant association with preeclampsia; however, one of the limitations acknowledged by the authors of the study is the fact that obese controls were not excluded for OSA, potentially affecting the association. A recent large population-based cohort study in Taiwan has examined the effects of PSG diagnosed OSA on adverse pregnancy and fetal outcomes [56] . This study identified 791 pregnant women with OSA and 3955 controls and compared the two groups for outcomes such as preeclampsia. The risk of preeclampsia and gestational hypertension in this study was found to be significantly elevated, even after adjusting for multiple confounders (adjusted OR 1.63, 1.07-2.48 and adjusted OR 3.18, 2.14-4.73, respectively). Interestingly, although the group with OSA had a significantly higher percentage of obese women than the control group (2.1% vs. 1.5%, p<0.001), the incidence of obesity is extremely low in the OSA group, suggesting a likely different mechanism for OSA in this population. Given that screening for OSA is quite low in many medical specialties and likely in obstetric specialties, the same limitation again applies to the group of controls that has not had the diagnosis of OSA excluded and has no data on screening for OSA documented.
A couple of case-control studies have evaluated the incidence of SDB in women with gestational hypertension, both with and without proteinuria [55, 59] . The first study used two alternative definitions for hypopneas which consisted of either 50-90% decrease in airflow, or a <50% reduction in airflow with a 4% desaturation or arousal (definition 1) or a stricter definition discounting events with <50% reduction in airflow (definition 2). In this study, there was a significantly higher likelihood of OSA using either definition for AHI in the group with gestational hypertension compared to the group with normotensive pregnancies [55] , but the AHI using definition 1 was higher than AHI using the more conservative definition (38.6 + 36.7 versus 21.6 + 35.2 respectively in the hypertensive group) [55] . In the second study, scoring was performed according to AASM criteria [62] and OSA defined as RDI > 5 [59] . This study also found a significantly higher incidence of OSA among the group with gestational hypertension compared to the normotensive group (53% vs. 12%) [59] . Interestingly, the hypertensive group was significantly more obese than the normotensive group (BMI 31.9 vs. 23.2, p<0.001) and had a larger neck circumference (38.6 cm vs. 34.2 cm, p<0.001). Earlier studies that had a more conservative definition for OSA (AHI >10) did not show evidence of the disorder in women with preeclampsia [63] .
Briefly, based on mainly cross-sectional studies, SDB including snoring and OSA appear to be associated with gestational hypertensive disorders, even after adjusting for multiple confounders. With such designs, the directionality of the association cannot be ascertained and longitudinal and mechanistic studies can help further our understanding of the link between these two disorders. A recent study suggests that the association with hypertension is significant in women who started snoring in pregnancy, compared to those who snored prior to pregnancy [64] . These findings would need to be confirmed in longitudinal designs. Despite all these studies suggesting a significant association with adverse outcomes, providers for the pregnant population are not screening appropriately for sleep symptoms such as snoring and witnessed apneas [65] .
POTENTIAL MECHANISMS
The underlying mechanism for the association of SDB with gestational hypertensive and other disorders has not been elucidated. Mechanistic pathways proposed in this manuscript are mostly hypothetical and remain to be tested.
Hypoperfusion, hypoxia and ischemia are important components in the pathogenesis of preeclampsia, because the ischemic placenta secretes a variety of soluble factors into the bloodstream that result in maternal endothelial dysfunction. Endothelial dysfunction is an early marker of vascular abnormalities that predates overt cardiovascular disease. Endothelial function can be assessed by various measures that detect its diverse functions of regulating vascular tone, maintaining a balanced pro-inflammatory / anti-inflammatory activity, coagulation homeostasis and endothelial repair function. Evidence suggests abnormal acetylcholine mediated vasorelaxation [66] and impaired flow-mediated vasodilation [67, 68] that persists three years after the diagnosis of preeclampsia [69] . Other evidence suggests decreased production of endothelial derived vasodilators, such as nitric oxide and prostacycline [70] . A study by Edwards et al. comparing pregnant women with preeclampsia and OSA to pregnant women with OSA but without preeclampsia showed that women with preeclampsia had higher blood pressure peaks following obstructive events than those without preeclampsia [71] . This study suggests that the augmented pressor response may be the result of endothelial dysfunction in preeclampsia.
Similar data are available in OSA where endotheliumdependent vasodilation has been shown to be reduced in non-pregnant patients with severe OSA compared to age and BMI matched controls [72, 73] . Reduced flow mediated dilation persisted after adjusting for co-morbidities in the Sleep Heart Health Study [74] . Other measures of reduced endothelial function have been found in OSA such as reduced levels of nitric oxide in the endothelial cells and the plasma, [75, 76] increased levels of endogenous NO synthase inhibitor, [77] and increased levels of circulating soluble adhesion molecules that mediate leukocyte adhesion to the vascular endothelium [78] as well as other measures of impaired vascular pro-inflammatory / anti-inflammatory homeostasis [79] .
There is a paucity of data assessing endothelial dysfunction as a potential mechanism for the association in pregnancy. One study has assessed sleep using a device that combines measurements of pulse, actigraphy, oxygen saturation and arterial vascular tone and measured endothelial function using non-invasive beat to beat plethysmography to measure arterial pulse wave amplitude [80] . The study showed a significant association between preeclampsia, OSA, and endothelial dysfunction in pregnant women [80] . Both intermittent hypoxia / reoxygenation [81, 82] and sleep fragmentation / deprivation secondary to repetitive arousals in OSA [83, 84] may lead to endothelial dysfunction.
In pregnancy, data from chronically hypoxic highaltitude residents suggest higher rates of preeclampsia and fetal growth restriction compared with low-altitude residents [85, 86] . There are limited data on the direct effect of intermittent hypoxia on pregnancy outcomes. Theoretically, given that endothelial dysfunction may be the common pathway between OSA and preeclampsia, intermittent hypoxia caused by OSA may potentially be the driving force causing endothelial dysfunction. However, a small number of PSG data in pregnant women diagnosed with OSA suggests that these women are diagnosed mainly on the basis of flow limitation and arousals rather than desaturations. A study that evaluated the incidence of OSA in women diagnosed with gestational hypertensive disorders has shown a significantly higher number of events when 4% desaturation was eliminated as a requirement for the definition of hypopnea [55] . Another more recent study with a similar design showed a mean AHI of only 3.1 + 6.2 in the group of women diagnosed with OSA based on RDI with mean of 11.5 + 11.2 [59] .
Other studies have found air flow limitations during sleep -without overt apneas -in women with either preeclampsia or risk factors for preeclampsia. A study by Connolly et al. measured an index of inspiratory flow limitation referred to as the flattening index in women with preeclampsia compared to a normotensive pregnant and a non-pregnant group [87] . The flattening index gives a measure of inspiratory flow limitation that is derived from the relationship of inspiratory flow to inspiratory duration. The study showed that despite a similar number of apneas and hypopneas in the case and the control groups, frequent, prolonged air flow limitations without significant desaturations were identified in patients with preeclampsia compared with normal pregnant and nonpregnant women. Edwards et al. have shown similar findings while using either visual measures of airflow limitations or following measurements of the area under the curve for tidal breaths of randomly selected epochs in each sleep stage [63] . Air flow limitations were also present in a noncontrolled study of patients with risk factors for preeclampsia [88] . In this study airflow limitation was defined as a reduction of 2-30% in the nasal cannula signal compared to baseline normal breathing [88] . As highlighted in these studies, airflow limitations appear to be present in women with preeclampsia or with risk factors for the disorder; however, these airflow limitations have been measured and defined very differently in the above studies.
On the other hand, treatment of patients with risk factors for preeclampsia and air flow limitations (but not SDB) with continuous positive airway pressure (CPAP) has shown beneficial blood pressure effects [88, 89] and improved fetal outcomes when compared with controls [89] . These findings indirectly suggest that even in the absence of hypoxia and reoxygenation, air flow limitation may have a role in causing hemodynamic changes in patients at risk for preeclampsia who do not have apneas or hypopneas. However, given the very small sample size in these studies, larger trials are needed to help answer this question.
Sympathetic stimulation and oxidative stress enhanced by hypoxia, flow limitation and sleep fragmentation are other potential mechanisms for the association of SDB and gestational hypertensive disorders. Sympathetic activation has been well established in OSA [90] . Higher levels of catecholamines are associated with higher blood pressure readings potentially contributing to, or worsening preeclampsia. Increased oxidative stress has also been demonstrated in OSA in non-pregnant patients [91, 92] . Very limited data examining the presence of oxidative stress in relation to SDB are available in pregnancy. One study has found that pregnant snorers had higher levels of oxidative stress markers such as malondialdehyde compared with nonsnoring pregnant controls [93] .
Inflammation is possibly another pathway for the association. Both short sleep duration and poor sleep have been associated with elevated levels of interleukin-6 in mid to late pregnancy [94, 95] and tumor necrosis factor alpha in late gestation [94] . The same inflammatory markers have been suggested in preeclampsia [96] .
Angiotensin converting enzyme (ACE) insertion / deletion (I/D) gene polymorphism has been studied as a possible common pathway for obstructive sleep apnea and chronic hypertension. Some studies have shown that the ACE D allele has either a protective effect against the development of hypertension in patients with OSA [97] or evidence of reciprocal interactions [98] . However, results are quite conflicting and a recent meta-analysis has shown a large male predominance in both cases and controls and no significant association [99] . The association of ACE I/D gene polymorphism with preeclampsia has also been evaluated; however, results are also conflicting with two meta-analyses, published a month apart, showing a possible significant association in one [100] but not the other [101] .
The placenta plays a central role in the development of preeclampsia as evidenced by epidemiologic and experimental data. These data suggest that the presence of a placenta -but not a fetus -is necessary for the development of preeclampsia, and that delivery of the placenta results in a cure. Maternal spiral arteries -small branches of the uterine artery -undergo remodeling early in gestation and are transformed from small muscular arteries into large capacitance arteries of low resistance capable of facilitating blood flow into the placenta in normal pregnancies. In preeclampsia, this phenomenon is defective and the abnormal placentation and resulting ischemia are thought to be the primary event leading to the release of soluble factors that cause the systemic reaction, triggering the clinical manifestations of preeclampsia. Despite this and the association of preeclampsia with SDB, the placenta has not been studied in this setting. We described a small case series of pregnant patients with OSA diagnosed following various clinical scenarios that had placental pathological changes similar to those seen in gestational diabetes or preeclampsia, even in the absence of a clinical diagnosis of these disorders [102] . It is possible that such changes may be related to confounders such as obesity; however, the effects of obesity on the placenta are not known either. Further studies of the effect of SDB on the placenta are needed.
Another direction of the association is also possible where preeclampsia, based on mechanical factors and fluid shifts, may predispose to the de novo development of OSA. Patients with preeclampsia have lower oncotic pressures than normal pregnant women; they also have a larger neck circumference and a smaller upper airway size [11] ; these factors are known predictors of SDB. Longitudinal studies evaluating the incident development of one disorder in the presence of the other would help answer this question.
GESTATIONAL DIABETES
Gestational diabetes is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. Reported rates of gestational diabetes range from 2 to 10 percent of pregnancies [103] but may be significantly higher depending on the definition used [104] . Gestational diabetes is associated with many pregnancy complications, including macrosomia, cesarean delivery, birth trauma, preterm delivery, preeclampsia and intrauterine fetal demise.
A growing body of evidence suggests an association of short sleep duration, snoring, OSA and gestational diabetes. In a cross sectional study performed at a tertiary care, university hospital on 1000 patients recruited in the immediate postpartum period, we demonstrated a significant association between gestational diabetes and third trimester snoring (aOR 2.1, 1.3-3.4, 95% CI) [4] . The association was much stronger when all three symptoms of snoring, gasping and witnessed apneas were present, and persisted after adjusting for age, BMI at delivery and multiple gestations (aOR 4.0, 1.4-11.1, 95% CI). Another cohort study by Qiu et al. [105] has evaluated snoring in early pregnancy. Although the study showed an elevated relative risk for gestational diabetes in overweight women who do not snore (aRR 2.85, 1.65-4.01 95%CI), the risk was much higher in overweight women who did snore (aRR 6.91, 2.87-16.6, 95% CI). Smaller studies showed that frequent snorers had higher glucose tolerance values [106] and a higher likelihood of gestational diabetes [107] .
The risk of GDM was also found to be higher in women with self-reported short sleep duration [105] [106] [107] . In the study by Facco et al., pregnant women with self reported short sleep duration defined as less than 7 hours of sleep was found to be at a significantly higher risk of having a 1h GTT > 130 and a diagnosis of GDM compared to women without short sleep duration [106] . In addition, mean 1-hour plasma glucose concentrations was highest for women who reported short habitual sleep duration and lowest in those who reported sleeping an average of 9 hours per night [105] .
A significant association was also found between polysomnographically diagnosed OSA and gestational diabetes in a cohort study in Taiwan, even after adjusting for confounders including gestational hypertension, obesity, parity and others (1.63, 1.07-2.48 CI 95%) [56] . A noteworthy fact in this study was the fact that although obesity was more common in the OSA group compared to controls, it was only found in 2.1% of cases and 1.5% of controls. This is a significant finding suggesting that the association may be independent of body habitus, a significant confounder in the western world.
POTENTIAL MECHANISMS
The etiology of abnormal glucose metabolism in relation to SDB may be related to sympathetic activation, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, intermittent hypoxia and oxidative stress, as well as inflammation. Increased sympathetic activation can be caused by airflow limitation, sleep fragmentation or intermittent hypoxia and can inhibit pancreatic insulin secretion, worsen insulin resistance, decrease glucose effectiveness and stimulate hepatic glucose release [108] [109] [110] [111] . Dysregulation of the HPA axis and glucocorticoid secretion worsen insulin resistance and inhibit insulin secretion by modifying the insulin mediated glucose transport system [112] .
Oxidative stress and reactive oxygen species result in pancreatic beta cell damage [113] resulting in a reduction in insulin secretion. Inflammation may be a potential mechanism linking gestational diabetes and SDB, with interleukin-6 and TNF-α being potential culprits [114] [115] [116] [117] [118] [119] [120] [121] . Oxidative stress, IL-6 and TNF-α all reduce levels of adiponectin, a hormone with anti-atherogenic and antiinflammatory properties. Adiponectin levels were also found to have a protective effect against endothelial injury [120] . Levels of this polypeptide are reduced in diabetes and OSA, with recent studies showing a significant reduction in women with gestational diabetes [120] .
PRETERM LABOR
Infants are born preterm at less than 37 weeks of gestation after either preterm premature rupture of the membranes, spontaneous labor with intact membranes, or labor induction or cesarean delivery for maternal or fetal indications. Preterm birth is a significant source of morbidity and mortality in newborns and accounts for 75% of neonatal mortality and more than half the long term morbidity [122] . Preterm labor is thought to be initiated by one or more of multiple mechanisms including infection or inflammation, uteroplacental ischemia or hemorrhage, overdistention of the uterus, or immunologically mediated processes. Although multiple obstetric and non-obstetric risk factors for preterm labor have been identified, obesity, an important risk factor for sleep disordered breathing, may play a protective role against spontaneous preterm labor [123] . On the other hand, obese women are more likely to develop preeclampsia or gestational diabetes, or have infants with congenital abnormalities and have more indicated preterm deliveries. However, according to a preterm prediction study evaluating BMI and the risk of preterm labor, women with a BMI of 30-34.9 had a 7.1% risk of spontaneous preterm birth and 5.8% risk of indicated preterm birth compared to 11.3% and 3.7% respectively in women with a BMI of 19-24.9 [124] .
Few studies have evaluated the association between preterm labor or preterm birth and SDB. Snoring [4] and OSA [57] have both been associated with preterm birth in cohort and case control studies. In a cross sectional study, [4] women with fetal or neonatal demise were excluded for compassionate reasons, possibly affecting the association. Based on the recruited sample, the association with preterm labor ceased to be statistically significant when the model was adjusted for preeclampsia occurring in the index pregnancy. Thus, preterm labor is likely mediated by the association with preeclampsia [4] . In the case control study, it appeared that indicated -but not spontaneous -preterm birth was significantly associated with OSA, with early delivery for preeclampsia being the most common cause for prematurity [57] . A recent population-based study showed a significant association between preterm births and OSA but did not adjust for preeclampsia in the regression model [56] .
Another cohort study with low incidence of snoring (4% of all pregnant women) showed no significant association between snoring and preterm birth [125] . However, the association between reported short sleep duration (<5 hours) and indicated that preterm delivery was significant, even after adjusting for age, pre-pregnancy BMI, maternal education and smoking.
Based on the current studies, it appears that OSA and snoring are not independent predictors of preterm birth and the association is more than likely related to confounders.
CESAREAN DELIVERIES
Maternal morbidities such as obesity that are often associated with cesarean delivery are also associated with OSA. Two recent studies have shown a relationship between OSA and cesarean delivery [56, 57] . In a univariate analysis of women diagnosed with OSA by PSG, those with OSA were at a significantly higher risk of cesarean delivery when compared to obese and normal weight women. OSA was also associated with wound complications which may be secondary to poor tissue perfusion. In multivariate analysis OSA was associated with composite maternal morbidity [57] . In a large retrospective cohort of Asian women, 50% of those with OSA diagnosed by PSG underwent a cesarean delivery compared to 37% without OSA. This difference in cesarean section rate between women with OSA and those without remained significant when a multivariate analysis was performed [56] . In a study evaluating the effect of snoring on mode of delivery self-reported snoring and gasping were associated with an increase in the number of unplanned, but not planned-cesarean section [4] . The study did not, however, examine whether unplanned cesarean deliveries were related to obstetric causes such as poor progression of labor, pelvic outlet dimensions or due to fetal compromise. Short sleep duration, defined as < 6 hours of sleep on actigraphy, was shown to increase the risk of having an unplanned cesarean delivery in 132 primiparous women [126] . These findings were contradictory to prior studies which have concluded that short self-reported sleep duration does not impact labor and delivery [127] .
These data suggest that women with snoring, short sleep duration or OSA may be at a higher risk of cesarean delivery and postoperative complications. Future studies are needed to evaluate the exact causes requiring Cesarean delivery to help clarify the role that snoring, OSA, sleep duration or sleep fragmentation play in this observation.
SUMMARY
SDB is associated with adverse pregnancy outcomes such as gestational hypertensive disorders and gestational diabetes mellitus. Although causality and mechanisms of such associations have not been clearly established, epidemiologic cohort studies and case control studies seem to support the association. Many mechanistic pathways are plausible in the association such as arousals, sleep fragmentation, flow limitations and intermittent hypoxia. The link between SDB and preterm birth is likely related to confounders such as preeclampsia. Finally, despite limited data, an association between SDB and cesarean delivery seems to exist but needs to be studied further.
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